I'm not an attorney and I'm not sure. I would think it's interesting information for our new general counsel/litigator. The devil is in the details in these agreements. If the arbitrator in this case again rules that Darzalex FasPro "constitutes a new licensed product", it may reinforce the argument that a co-formulation patent should be issued, and we know that would affect the agreement with Halo.
News 
Market Data 
Discover 
